Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 7-week, Open Label, Single Arm Study Evaluating the Efficacy and Safety of Omnilux Clear® on Mitigating Mild to Moderate Acne in Healthy Male and Female Teenagers and Adults

NCT06936332 is registered in ClinicalTrials.gov with Ablon Skin Institute Research Center as lead sponsor.

NCT NCT06936332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06936332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 7-week, Open Label, Single Arm Study Evaluating the Efficacy and Safety of Omnilux Clear® on Mitigating Mild to Moderate Acne in Healthy Male and Female Teenagers and Adults
Lead sponsor
Ablon Skin Institute Research Center
Phase
Not applicable
Overall status
Completed
Start date
November 18, 2024
Completion date
April 10, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne